|
Characteristics
|
No of patients [cases (%)]
|
|---|
|
Sex
|
|
Female
|
14 (25.9)
|
|
Male
|
40 (74.1)
|
|
Treatment
|
|
Induction and concurrent chemoradiotherapy
|
24 (44.4)
|
|
Concurrent chemoradiotherapy
|
29 (53.7)
|
|
Radiotherapy alone
|
1 (1.9)
|
|
Staging (AJCC/UICC 2010)
|
|
T stage
|
|
T4
|
14 (25.9)
|
|
T3
|
24 (44.4)
|
|
T2
|
9 (16.7)
|
|
T1
|
7 (13.0)
|
|
N stage
|
|
N3b
|
2 (3.7)
|
|
N3a
|
6 (11.1)
|
|
N2
|
34 (62.9)
|
|
N1
|
11 (20.4)
|
|
N0
|
1 (1.9)
|
|
M stage
|
|
M0
|
54 (100)
|
|
M1
|
0 (0)
|
|
TNM stage
|
|
IVb
|
6 (11.1)
|
|
IVa
|
17 (31.5)
|
|
III
|
29 (53.7)
|
|
II
|
2 (3.7)
|
- UICC the Union for International Cancer Control, AJCC the American Joint Committee on Cancer
